Morning Overview on MSN
The Alzheimer’s drug memantine was tied to a higher risk of irregular heartbeat
Older adults taking memantine for Alzheimer’s disease may face a higher risk of irregular heartbeats, according to a growing body of evidence drawn from electronic health records and adverse-event ...
Murj®, a cardiac device management software company, today announced its official expansion into the Australian market alongside broader availability for New Zealand. Following its exhibition at the ...
Background Preparticipation cardiovascular evaluation (PPE) is widely recommended to reduce the risk of sudden cardiac events ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Lauren Dragan Lauren Dragan writes about audio tech and OTC hearing aids. She ...
Ambulatory patch device designed to aid in detecting ischemia and complex arrythmias Targets a $2 billion market with established reimbursement; ischemia detection has potential to disrupt the patch ...
The critical system of ocean currents which loops around the Atlantic Ocean is weakening and could be far closer to collapse than previously thought, according to two new studies — an event which ...
Alivecor Inc. has secured CE marking for its Kardia 12L electrocardiogram (ECG) system, which is powered by its KAI 12L AI technology and can detect life-threatening cardiac conditions. Kardia 12L is ...
Copper moves the world’s heat. For more than a century it has been recognized as one of the best heat conductors in nature, and this property made copper the go-to choice to cool electronics, ...
Medtronic got an FDA approval for its OmniaSecure defibrillation lead, opening up its use in the heart’s left bundle branch, while Biotronik touted the commercial rollout of its Solia CSP S lead.
Conduction-system pacing (CSP) was put to the test in two randomized trials of patients requiring cardiac resynchronization therapy (CRT) for left bundle branch block (LBBB)—the HeartSync-LBBP and ...
Discordant results from two trials comparing conduction system pacing with biventricular pacing for cardiac resynchronization therapy (CRT) leave open the question of whether conduction system pacing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results